PCBL Chemical Limited Approves Audited Financial Results for FY26 and Q4FY26
PCBL Chemical Limited's Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The auditors issued an unmodified opinion. The company also provided details on security cover for its debt, including a pledge over Aquapharm Chemical Limited shares.
The approval of financial results is a material event for investors. The inclusion of details regarding security cover for debt also provides important financial information.
The announcement reports the approval of financial results and related audit reports, which is a routine disclosure. No specific financial performance figures or forward-looking statements are detailed in the provided text to indicate a positive or negative sentiment.
PCBL Chemical Limited announced the outcome of its Board Meeting held on April 30, 2026. The Board of Directors considered and approved the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026.
The company has enclosed a copy of the Audited Financial Results, Statement of Assets and Liabilities, Cash Flow Statement, and Auditors’ Report with an unmodified opinion. The full financial results will be available on the websites of the National Stock Exchange (NSE) and BSE, as well as on the company's website. The Board Meeting commenced at 12 noon and concluded at 1:46 p.m.
Additionally, the company declared that its Statutory Auditors, M/s. SR Batliboi & Co. LLP, have issued an audit report with an unmodified opinion on the financial results for the financial year ended March 31, 2026. The announcement also included details regarding the security cover for its debt instruments, specifically the first ranking exclusive pledge over shares of Aquapharm Chemical Limited.
What to do with a filing like this
PCBL Chemical Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by PCBL Chemical Limited. Read the original for the full detail.